证券代码：000930 证券简称：中粮科技 公告编号：2023-061 中粮生物科技股份有限公司 关于公司董事长、董事辞职的公告 任晓东女士因工作原因，申请辞去公司董事职务。 按照《公司法》和《公司章程》的规定，殷建豪先生、任晓东女士的辞职 报告自送达公司董事会之日起生效, 殷建豪先生、任晓东女士辞职后，不再担 任上市公司任何职务。截至本公告披露日，殷建豪先生、任晓东未持有公司股 票。 殷建豪先生、任晓东女士辞职不会导致公司董事会成员低于法定人数的情 形，根据《公司法》及《公司章程》相关规定，公司将按照法定程序完成董事 补选、董事长选举等工作。 殷建豪先生、任晓东女士在公司任职期间勤勉尽责，认真履职，公司董事 会对殷建豪先生、任晓东女士为公司发展做出的贡献表示衷心感谢。 特此公告。 中粮生物科技股份有限公司 董 事 会 2023 年 12 月 15 日 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 中粮生物科技股份有限公司（以下简称公司）董事会于近日收到公司董事 长、董事殷建豪先生,董事任晓东女士提交的书面辞职报告。 殷建豪先生因工作原因，申请辞去公司董事 ...

证券代码：000930 证券简称：中粮科技 公告编号：2023-060 3.会议召集的合法、合规性：本次会议的召开符合有关法律、行政法规、部 门规章、规范性文件和《公司章程》相关规定和要求。 4.会议时间： 现场会议召开时间：2024 年 1 月 2 日（星期二）14:30 网络投票时间：通过深交所交易系统进行网络投票时间为 2024 年 1 月 2 日 9:15-9:25、9:30-11:30、13:00-15:00；通过深交所互联网投票时间：2024 年 1 月 2 日 9:15-15:00。 中粮生物科技股份有限公司 关于召开 2024 年第一次临时股东大会的通知 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 中粮生物科技股份有限公司（以下简称公司）第八届董事会 2023 年第五次 临时会议审议通过了《关于提请召开公司 2024 年第一次临时股东大会的议案》， 现将有关事项公告如下： 一、召开会议的基本情况 1.股东大会届次：2024 年第一次临时股东大会 2.股东大会的召集人：公司董事会 5.会议召开方式：现场表决与网络投票相结合。 公司将通过深交所交易 ...

证券代码： 000930 证券简称：中粮科技 中粮生物科技股份有限公司投资者关系活动记录表 编号：2023-005 油价与成本是影响燃料乙醇盈利能力的两个重要因素。近期 油价上涨拉动销量，也一定程度提振了燃料乙醇市场销售价格。 燃料乙醇产能总体上还是供大于求，目前的燃料乙醇价格总体平 稳，公司将通过降低原料成本扩大燃料乙醇的利润空间。 3.公司燃料乙醇的开工率如何？行业开工率大约在 53%？ 公司酒精产能利用率比较稳定，开工率接近 100%，远高于 行业平均水平。公司通过采取柔性生产，酒精类产品的细分品类 众多，包括医用、食用、电池电解液、燃料乙醇等，拓宽了下游 应用领域，能够更好的保证开工率；公司燃料乙醇的市场占有率 接近 40%，也能保证较高开工率。 4.公司非粮燃料乙醇（如纤维燃料乙醇）的进展？ 目前公司纤维素乙醇还没有实现产业化，成本下降还需要过 程，需要不断的研发创新和技术进步。 | □特定对象调研 | □ 分析师会议 | 投资者关系活动 | | --- | --- | --- | | □ 媒体采访 | □ 业绩说明会 | 类别 | | | 路演活动 | | | □ | | | | √ 其他 | （ ...

Financial Performance - The company's revenue for Q3 2023 was CNY 5,411,119,957.49, representing a 26.22% increase compared to CNY 4,287,062,608.64 in the same period last year[7]. - Net profit attributable to shareholders was CNY 2,376,698.22, a significant decrease of 98.68% from CNY 179,738,947.16 year-on-year[7]. - The net profit after deducting non-recurring gains and losses was CNY -12,671,010.69, down 107.65% from CNY 165,606,253.04 in the previous year[7]. - The company's total revenue for the year-to-date was CNY 14,721,188,587.73, reflecting a slight decrease of 1.18% from CNY 14,896,319,948.47 in the previous year[11]. - Total operating revenue for the period reached CNY 14,721,188,587.73, a decrease of 1.17% compared to CNY 14,896,319,948.47 in the previous period[28]. - Net profit for the period was CNY -345,328,717.95, compared to a net profit of CNY 987,536,654.28 in the previous period[30]. - Basic earnings per share were reported at CNY -0.1818, compared to CNY 0.5196 in the previous period[30]. Cash Flow - The company's cash flow from operating activities for the year-to-date was CNY 1,266,726,046.49, a decrease of 22.77% compared to CNY 1,640,249,107.89 last year[11]. - The net cash flow from operating activities was CNY 1,266,726,046.49, a decrease of 22.8% compared to the previous period's CNY 1,640,249,107.89[33]. - Cash inflow from operating activities totaled CNY 18,029,755,562.06, down from CNY 19,695,329,892.23, reflecting a decline of 8.5%[33]. - Cash outflow from operating activities decreased to CNY 16,763,029,515.57 from CNY 18,055,080,784.34, a reduction of 7.1%[33]. - Cash inflow from investing activities was CNY 172,130,941.64, compared to CNY 95,284,720.32 in the previous period, an increase of 80.7%[33]. - The net cash flow from investing activities was CNY -336,908,785.03, slightly worse than the previous period's CNY -326,773,895.24[33]. - Cash inflow from financing activities increased to CNY 6,324,030,563.86 from CNY 4,270,175,921.38, a growth of 48.0%[36]. - The net cash flow from financing activities was CNY -254,477,525.16, an improvement from CNY -1,063,921,214.31 in the previous period[36]. - The ending balance of cash and cash equivalents was CNY 1,623,240,203.67, up from CNY 1,386,760,889.24, reflecting an increase of 17.0%[36]. - The company received CNY 44,100,000.00 from minority shareholders during the period[36]. - The company reported a decrease in tax payments to CNY 330,572,016.28 from CNY 421,469,429.27, a decline of 21.6%[33]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 18,100,294,856.56, a decrease of 3.81% from CNY 18,125,612,523.97 at the end of the previous year[7]. - The total assets amount to CNY 17,435,053,890.46, indicating a decrease from the previous period[22]. - The company's equity attributable to shareholders is CNY 10,702,787,627.03, down from CNY 12,094,927,414.69 in the previous period[22]. - The total liabilities amount to CNY 6,371,735,725.11, with current liabilities at CNY 5,864,520,245.89[22]. - The company reported a decrease in short-term borrowings to CNY 3,840,921,568.65 from CNY 2,874,376,515.71[22]. - The total equity at the end of the reporting period is CNY 11,063,318,165.35[22]. - The company has a capital reserve of CNY 6,134,181,866.07, slightly down from CNY 6,134,567,351.63[22]. Research and Development - The company's R&D expenses increased by 16.50% to CNY 113,048,188.82 compared to CNY 97,035,272.22 in the same period last year[11]. - The company reported a significant increase in research and development expenses, totaling CNY 113,048,188.82, up from CNY 97,035,272.22 in the previous period[28]. Shareholder Information - COFCO Bio-chemical Investment Co., Ltd. holds 47.37% of the total shares, amounting to 883,233,262 shares[15]. - The total number of common shareholders at the end of the reporting period is 121,921[15]. - The total number of preferred shareholders is not applicable for this reporting period[19]. - The company has no known related party relationships among shareholders[18]. Financial Expenses - The company experienced a significant increase in financial expenses, primarily due to an increase in loan scale during the reporting period[11]. - The company recorded a financial expense of CNY 64,460,820.29, compared to a financial income of CNY -8,053,157.05 in the previous period[28]. Other Comprehensive Income - Other comprehensive income after tax was CNY -6,088,195.11, down from CNY 37,309,891.11 in the previous period[30]. Return on Equity - The weighted average return on equity was 0.02%, down from 1.53% in the previous year[7]. Inventory - The company’s inventory decreased to CNY 3,086,256,526.18 from CNY 3,763,200,002.79, a reduction of 18.00%[25]. Cash and Cash Equivalents - Cash and cash equivalents increased to CNY 1,625,340,127.93 from CNY 1,016,637,250.32, representing a growth of 59.93%[25].

证券代码：000930 证券简称：中粮科技 公告编号：2023-055 中粮生物科技股份有限公司 八届六次董事会决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 一、会议出席情况 二、议案审议情况 1．以 8 票同意、0 票反对、0 票弃权的表决结果审议通过了《公司 2023 年第三 季度报告》。 具体内容详见同日刊登在巨潮资讯网（http://www.cninfo.com.cn）、《中国证 券报》、《证券时报》、《证券日报》、《上海证券报》的相关公告。 三、备查文件 1.公司八届六次董事会决议。 特此公告。 中粮生物科技股份有限公司 董 事 会 2023 年 10 月 26 日 中粮生物科技股份有限公司（以下简称公司）于 2023 年 10 月 15 日分别以传真 和专人送达的方式向公司全体董事、监事和高级管理人员发出召开公司八届六次董事 会会议的书面通知。会议于 2023 年 10 月 26 日如期召开。在保障所有董事充分表达 意见的情况下，本次董事会采用通讯方式进行表决。本次董事会会议材料同时提交公 司监事及高级管理人员审阅。会议应参加表决董事 8 ...

本公司及监事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、监事会会议召开情况 中粮生物科技股份有限公司（以下简称公司）于 2023 年 10 月 15 日分别以 传真和专人送达的方式向公司全体监事发出召开公司八届六次监事会会议的书 面通知。会议于 2023 年 10 月 26 日如期召开。在保障所有监事充分表达意见的 情况下，本次监事会会议采用通讯方式进行表决。会议应参加表决监事 3 人，实 际参加表决的监事共 3 人，参加表决的监事有：王来春先生、高岩蕊女士、李智 先生，符合《公司法》和《公司章程》的相关规定。 二、监事会会议审议情况 以 3 票同意、0 票反对、0 票弃权的表决结果审议通过了《公司 2023 年第三 季度报告》 证券代码：000930 证券简称：中粮科技 公告编号：2023-056 中粮生物科技股份有限公司 八届六次监事会决议公告 特此公告。 中粮生物科技股份有限公司 监 事 会 2023 年 10 月 26 日 1 三、备查文件 公司八届六次监事会决议。 ...

Group 1: Event Details - The company will participate in the "2023 Anhui Listed Companies Investor Online Reception Day" [2] - The event will be held online on September 12, 2023, from 15:30 to 17:30 [2] - Investors can join via the "Panorama Roadshow" website, WeChat, or the Panorama Roadshow APP [2] Group 2: Communication Focus - Company executives will discuss the 2023 half-year performance, corporate governance, development strategy, and operational status [2] - The event aims to enhance interaction and communication with investors [2] Group 3: Assurance of Information - The company and its board guarantee the announcement's content is true, accurate, and complete, with no false statements or omissions [2]

证券代码： 000930 证券简称：中粮科技 中粮生物科技股份有限公司投资者关系活动记录表 编号：2023-004 | 投资者关系活动 □特定对象调研 | 分析师会议 | □ | | | --- | --- | --- | --- | | 类别 □ 媒体采访 | □ 业绩说明会 | | | | 新闻发布会 □ | 路演活动 | | □ | | 现场参观 □ | | | | | √ 其他 | （投资者交流会） | | | | 中信证券 罗寅 参与单位名称及 | 黎刘定吉 王聪、嘉实基金 刘楷尧、趣时资产 | | | | 施桐、朱雀投资 | 刘丛丛、中庚基金 刘晟、北京征金资本管理 | | | | 有限公司 | 卜长海、恒源资产 温俊峰、鸿商集团 王竞达、民族 | | | | 证券自营 | 黄鹏、诺德基金 史东骏、上海环懿基金 常先通、上 | | | | 海浦科飞人投资有限公司 | 陈加栋、申万宏源证券自营 屈灵玉、 | | | | 涌贝资产 | 马涌超、众行远基金 高骐。 | | | | 时间 年 月 日 2023 8 28 | (周一) 上午 10:30~11:30 | | | | 地点 中粮广场 A 座 7 ...

Financial Performance - The company's revenue for the agricultural products processing and sales segment was CNY 9,145,252,604.67, a decrease of 12.91% compared to the same period last year[14]. - The gross profit margin for the fuel ethanol and its by-products segment was 3.27%, down 10.42% year-on-year[14]. - The net profit of COFCO Biochemical (Thailand) Co., Ltd. decreased by 46.01% due to a decline in citric acid product prices[25]. - The company reported a total non-operating income of CNY 25,302,414.99 after tax impacts and minority interests[6]. - The company reported a total asset value of approximately 2,412.78 million RMB for its subsidiary, with a net asset value of approximately 1,491.43 million RMB[52]. - The company experienced a net loss of approximately 61.58 million RMB for its subsidiary engaged in fuel ethanol production[52]. - The company’s subsidiary in Thailand reported a net profit of approximately 118.83 million RMB, with total revenue of approximately 577.56 million RMB[52]. Market Position and Strategy - The company achieved a market share of over 60% for anhydrous ethanol and 50% for pharmaceutical ethanol in the South China market[10]. - The company has implemented a "bulk + specialty" business strategy to enhance market expansion and customer relationships[10]. - The company is focusing on carbon management and has initiated a carbon verification process to support its dual carbon goals[9]. - The company has increased the proportion of direct procurement from coal mines to over 65% to reduce procurement costs[9]. - The company plans to maintain a reasonable level of raw material inventory to mitigate risks from price fluctuations[26]. - The company is facing challenges from global inflation and geopolitical conflicts affecting commodity prices, impacting operational decisions[26]. Environmental Compliance and Monitoring - The company has established a monitoring plan in compliance with environmental regulations, focusing on parameters such as COD, ammonia nitrogen, and total phosphorus[12]. - The company’s monitoring activities are conducted quarterly and semi-annually, ensuring compliance with pollution discharge permits[12]. - The company’s monitoring personnel are required to be trained and certified, ensuring the accuracy of monitoring processes[12]. - The company has established annual self-monitoring plans and strictly adheres to them for environmental monitoring across its subsidiaries[91]. - The monitoring indicators include COD, ammonia nitrogen, total nitrogen, total phosphorus, pH, and flow rate, ensuring compliance with environmental standards[91]. - The company has implemented emergency response plans for environmental risks, with a total of 8 specialized emergency plans developed across subsidiaries[67]. - The company conducted 4 emergency drills in 2022 to ensure preparedness for environmental incidents[67]. - The company has complied with the Environmental Protection Tax Law, timely paying taxes related to air and water pollution[68]. - The company has maintained compliance with monitoring standards, conducting quarterly comparative monitoring for various pollutants[70]. - The company has ensured that all monitoring data is publicly available, either through local environmental department websites or electronic displays at company entrances[69]. Legal and Regulatory Matters - The company faced a lawsuit regarding a labor service dispute, which was withdrawn by the plaintiff, resulting in no liability for the company[136]. - The company successfully pursued a lawsuit against a heating supply company, with the court ruling in favor of the company, and the case has entered the execution phase[136]. - The company is currently involved in multiple ongoing legal disputes, including a labor dispute with a former employee, with hearings scheduled for July and August 2023[137]. - The company has not engaged in any asset or equity acquisitions or sales during the reporting period[142]. - The company has faced various labor-related arbitration cases, with most claims being dismissed by the labor arbitration committee[137]. - The company has achieved a favorable ruling in a contract dispute with a local heating company, which has also entered the execution phase[137]. - The company is currently in the process of resolving a construction contract dispute, with hearings scheduled for July 2023[136]. - The company has not reported any significant changes in related party transactions during the reporting period[141]. Rural Revitalization and Social Responsibility - The company is committed to supporting rural revitalization, focusing on five major actions: industry, talent, culture, ecology, and organization[102]. - The company plans to explore a "grain bank" storage and sales model and an "order agriculture" production and sales model[102]. - The company aims to create a full industry chain operation model from farm to table[102]. - The company has held four meetings to discuss and implement rural revitalization strategies in line with national policies[102]. - The company has received government subsidies amounting to CNY 600,000 for rural revitalization projects, supporting agricultural development in Tibet[125]. - The company has established a long-term mechanism to prevent large-scale poverty return, demonstrating its commitment to social responsibility[125]. - The company has committed to promoting "order agriculture" and analyzing demand for crops to optimize planting strategies for 2024[125]. Financial Management and Receivables - The total balance of other receivables at the end of the period is CNY 163,781,301.23, an increase from CNY 155,888,923.09 at the beginning of the period, representing a growth of approximately 10.2%[77]. - The company has received dividends from Jilin Fuel Ethanol Co., Ltd. amounting to CNY 295,999.39 at the end of the period[75]. - The company is focused on enhancing its bad debt management strategies to mitigate future credit risks[82]. - The company reported a total accounts receivable balance of CNY 66,694,226.16, down from CNY 123,049,898.14 at the beginning of the period, indicating a significant reduction of approximately 45.5%[121]. - The company has no violations regarding external guarantees during the reporting period, ensuring compliance with regulatory standards[108]. - The company has not recorded any bad debt provisions during the reporting period[147]. - The company’s receivables from major clients account for 24.56% of total accounts receivable, highlighting a concentration risk[118]. - The company’s accounts receivable from COFCO Coca-Cola and other major clients are closely monitored to manage credit risk effectively[118]. Corporate Governance and Shareholder Matters - The company approved the Restricted Stock Incentive Plan and its summary during the board meeting on September 20, 2019[29]. - The company announced the list of incentive objects for the Restricted Stock Incentive Plan from December 5 to 15, 2019, with no objections received during the public notice period[29]. - The supervisory board confirmed that all proposed incentive objects meet relevant legal and regulatory requirements[29]. - The company held its first temporary shareholders' meeting in 2023, with a participation rate of 55.50%[55]. - 中粮集团承诺在资产重组后避免同业竞争，确保中小股东的合法权益[132]. - 中粮集团将促使附属公司在资产重组完成后3年内解决相关房产和土地瑕疵问题[132]. - 中粮集团在本次重组中承诺股份锁定期为12个月，已到期解除[132]. - 中粮生物科技股份有限公司的股份变动情况显示，有限售条件股份由13,161,920股减少至8,286,602股，比例从0.71%降至0.44%[198]. - 中粮生物科技股份有限公司的无限售条件股份由1,852,111,676股增加至1,856,433,959股，比例从99.29%增至99.56%[198].

一、会议出席情况 中粮生物科技股份有限公司（以下简称公司）于 2023 年 8 月 14 日分别以传真和 专人送达的方式向公司全体董事、监事和高级管理人员发出召开公司八届五次董事会 会议的书面通知。会议于 2023 年 8 月 25 日在北京市东城区建国门内大街 8 号中粮广 场 A 座 7 层 5 号会议室如期召开。在保障所有董事充分表达意见的情况下，本次董事 会采用现场结合通讯方式进行表决。本次董事会会议材料同时提交公司监事及高级管 理人员审阅。会议应参加表决董事 8 人，实际参加表决的董事共 8 人，参加表决的董 事有：殷建豪先生、张德国先生、任晓东女士、石碧先生、王尚文先生、任发政先生、 陈国强先生、李世辉先生，符合《公司法》和《公司章程》的相关规定。 证券代码：000930 证券简称：中粮科技 公告编号：2023-049 中粮生物科技股份有限公司 八届五次董事会决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 公司独立董事对半年报相关事项发表了独立意见。 二、议案审议情况 1．以 8 票同意、0 票反对、0 票弃权的表决结果审议通过了《关于公司会 ...